MedPath

Prediction of Postsurgical Symptomatic Outcomes With Preoperative Pessary Use

Not Applicable
Completed
Conditions
Uterine Prolapse
Pelvic Organ Prolapse
Vaginal Vault Prolapse
Pelvic Floor Prolapse
Interventions
Device: Preoperative Pessary Use
Registration Number
NCT02680145
Lead Sponsor
Mayo Clinic
Brief Summary

This is a single center, prospective trial of pessary use prior to reconstructive pelvic floor surgery for pelvic organ prolapse. The goal of the study is to evaluate the change in pelvic floor symptoms with pessary use and subsequent reconstructive surgery. Additionally, we will assess the impact that preoperative pessary use has on patient self-reported preparedness for surgery.

Detailed Description

It is anticipated that this trial will define the clinical utility of routine preoperative pessary placement, and by shaping patient expectations and increasing preparedness for surgery, we anticipate improving satisfaction and quality of life.

At the initial office visit baseline symptoms are evaluation with validated questionnaire.

The patients' will undergo pessary fitting at least 7 days (but no more than 28 days) prior to scheduled surgical prolapse repair.

Symptomatic change from baseline will be assessed with validated questionnaire preoperatively.

The pessary will be removed at the time of surgery, and the patient will undergo surgical correction of their pelvic organ prolapse (including all restorative surgical procedures, abdominal and transvaginal). A concomitant anti-incontinence procedure will be performed at the discretion of the treating physician in consultation with the patient.

The patients' symptomatic outcome from surgery will then be reassessed by validated questionnaire at 6 weeks and 3 months postoperatively.

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
58
Inclusion Criteria
  • Older than 18 years of age
  • With symptomatic pelvic organ prolapse
  • Electing for surgical repair of pelvic organ prolapse (transvaginal or transabdominal) at least 7 days after office consultation
  • Understand and have signed written informed consent for preoperative pessary placement.
Exclusion Criteria
  • Previous use of a pessary for pelvic organ prolapse
  • Patients undergoing obliterative prolapse surgery (i.e. Colpocleisis),
  • Are scheduled for surgery for pelvic organ prolapse less than 7 days after office consultation or greater than 4 weeks after office consultation
  • Have an isolated rectocele
  • Have allergies to both latex and silicone
  • Have an active pelvic infection

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Preoperative Pessary UsePreoperative Pessary UseAll patients will use a pessary for 1-4 weeks preoperatively to reparative surgery for pelvic organ prolapse
Primary Outcome Measures
NameTimeMethod
Prolapse Symptom SeverityBaseline, 3 month post surgery

Mean value of score on self-reported Pelvic Organ Prolapse Distress Inentory-6 (POPDI-6) questionnaire. Minimum scale score = 0; maximum scale score = 100 and a higher score indicates worse outcome.

Patient Global Impression of Improvement (PGI-I) Score3 months postoperatively

Number of participants considered treatment success assessed using the 7-point Likert scale of the Patient Global Impression of Improvement (PGI-I) of 1= very much better and 7=very much worse. Patient's will be considered treatment success if they answer "much better" or "very much better" on the PGI-I scale.

Bother of Bladder/Vaginal/Bowel SymptomsBaseline, 3 month post surgery

Mean value of score on self-reported Floor Impact Questionnaire-7 (PFIQ-7). Minimum scale score = 0; maximum scale score = 100 and a higher score indicates worse outcome.

Overactive Bladder Symptom Score (OABSS)Baseline, 3 month post surgery

Mean value of score on self-reported Overactive Bladder Symptom Score (OABSS) questionnaire. Minimum scale score = 0; maximum scale score = 15 and a higher score indicates worse outcome.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Mayo Clinic

🇺🇸

Rochester, Minnesota, United States

© Copyright 2025. All Rights Reserved by MedPath